Journal
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
Volume 33, Issue 6, Pages 285-291Publisher
MARY ANN LIEBERT, INC
DOI: 10.1089/jir.2012.0086
Keywords
-
Funding
- National Natural Science Foundation of China [30972946]
- Zhejiang Provincial Natural Science Foundation of China for Distinguished Young Scholars [R2110125]
Ask authors/readers for more resources
Interleukin (IL-35) is a newly identified heterodimeric cytokine belonging to the IL-12 family. It contains Epstein-Barr virus-induced gene 3 subunit and IL-27 p35 subunit. Although its receptor and signaling pathway are not clear, we presumed that its receptor is composed by two chains that might be similar to those receptors of IL-12, IL-23, and IL-27. We also believe that the signal transducer activator of transcription family members is involved in its signaling pathway. It was reported that IL-35 could suppress Teff cell proliferation and Th17 development. It was considered to have a potential therapeutic effect against immune diseases. In our perspective, the finding of IL-35 is of great significance, since it can regulate T cells, which is an important therapeutic target of immunological disorders. IL-35 would promote the development of different kinds of vaccines, even vaccine for special cancer, and be promising to cure autoimmune and inflammatory diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available